Forest Laboratories Sets $1.8B High Yield Bond Deal Backing Aptalis Buy |
| January 27, 2014 | January 2014 Bond Updates |
|
Drug-maker Forest Laboratories has entered the market this morning with a $1.8 billion, two-part senior offering to fund the acquisition of Aptalis. The deal, comprising five-and seven-year bullet notes, comes off the shadow backlog and will be pitched in a 10:00 a.m. EST conference call, with pricing this afternoon, sources said. |
| View more at: http://www.forbes.com/sites/spleverage/2014/01/27/forest-laboratories-sets-1-8b-high-yield-bond-deal-backing-aptalis-buy/ |
| Related News |
|